MILAN – Several important clinical trials in progressive multiple sclerosis (MS) will provide results within the next couple years and will potentially help guide the field toward better […]
(Reuters) -Edwards Lifesciences Corp on Wednesday reported a rise in third-quarter sales, but lower-than-expected sales of the company’s artificial heart valves pushed the device maker’s shares […]
TOPLINE: Among the 3188 people with type 2 diabetes who were adherent to their tirzepatide (Mounjaro, Lilly) regimen in four pivotal trials of the agent, a […]
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. TOPLINE: The risk for Guillain-Barré syndrome (GBS) is six times higher in […]
MILAN — While multiple sclerosis (MS) is “one of two or three great success stories of modern molecular medicine,” we’re still only “halfway home,” University of California, San Francisco, […]
(Reuters) – Danish pharmaceutical company Bavarian Nordic said on Wednesday a U.S. Centers for Disease Control and Prevention panel has voted in favor of recommending the […]
MILAN — Two physicians agreed that there’s no doubt that Epstein-Barr virus (EBV) is deeply linked to multiple sclerosis (MS), but they diverged over the extent of its […]
The anti-inflammatory agent colchicine, started within 24 hours of acute ischemic stroke or a transient ischemic attack (TIA), was not associated with a reduction in subsequent […]
TOPLINE: Serum vitamin D levels are significantly lower and the prevalence of vitamin D deficiency is significantly higher in patients with ulcerative colitis (UC) compared with […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.